Abcellera Biologics Inc
Biotechnology
Healthcare
ABCL
298 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.03
52 week high
5.15
high
5.04
52 week low
0.00
low
4.84
growth
89.19 %
previous Close
4.83
P/E ratio
market cap
1.27 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
1077.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top